Fecal Calprotectin and the Clinical Activity Index Are Both Useful to Monitor Medical Treatment in Patients with Ulcerative Colitis

  • E. B
  • C. B
  • S. V
 et al. 
  • 2


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Methods: Forty-one patients with ulcerative colitis were included in a prospective observational study. Medical treatment was guided by clinical judgement of treating physicians. Fecal calprotectin and the clinical activity index (CAI) were measured blinded to treating physicians every 2 months until the end of follow-up. Twenty-six patients received colonoscopy for clinical reason.

Author-supplied keywords

  • colonoscopy
  • drug therapy
  • human
  • patient
  • physical disease by body function
  • therapy
  • ulcerative colitis

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Burri E.

  • Beglinger C.

  • Von Felten S.

  • Lehmann F.S.

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free